Dr. Jennifer S. Singer, MD

Dr. Singer practices at Peter Morton UCLA Medical Building in Los Angeles, California.

Dr. Singer's NPI, 1992725170, was assigned on July 20, 2006. Dr. Singer graduated from David Geffen School of Medicine at UCLA in 1996. Dr. Singer's California license number on file is A65375.

Dr. Singer's primary practice is Peter Morton UCLA Medical Building, at 200 Medical Plz, Los Angeles, CA 90024 in Los Angeles County. The practice phone is (310) 794-9206.

Dr. Singer's primary practice is Peter Morton UCLA Medical Building in Los Angeles, California. Dr. Singer is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is UCLA Urology. Dmand AI also links Dr. Singer to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singer practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Singer's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Singer is board certified in clinical informatics by the American Board of Preventive Medicine. Dmand AI has Dr. Singer's licenses on file in 2 states: California and Texas.

Dmand AI lists bladder disease, kidney stone disease, urinary endoscopy and UTI among the conditions Dr. Singer treats.

CMS data shows 14 Medicare services from Dr. Singer across 1 procedure code in 2022, all of them office visits, for 13 Medicare patients. Medicare paid $1,131 for them. Every service was in an office.

CMS counts 13 Medicare patients who saw Dr. Singer in 2024. The largest group is under 65, with 13 patients. 100% are also on Medicaid. Their average risk score is 4.05, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singer's median patient age at 9, with 30% women.

In 2024, Dr. Singer wrote 46 Medicare Part D claims. 89% of them were for generic drugs. CMS names the drug for 26 of them, across 2 drugs with 11 or more claims each, at $650 in total drug cost. In 2023, CMS named 35 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Singer for performance year 2024, reported as part of a group. Dr. Singer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Singer as offering telehealth.

Dmand AI links 2 papers to Dr. Singer.

CMS Open Payments shows 56 general payments to Dr. Singer from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 90% of the total. Rochester Medical Corporation paid the most, $332.

Dmand AI lists 2 awards for Dr. Singer, most recently LA Magazine Top Doctor in 2022.

Dr. Singer graduated from David Geffen School of Medicine at UCLA in 1996.

Dr. Singer is in network with 13 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 7. Check the plan with the practice before a visit.